Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by StockNews.com
Investment analysts at StockNews.com started coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Price Performance Shares of BCLI opened at $1.44 on Wednesday. The stock has a market capitalization of […]
Investment analysts at StockNews.com started coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Price Performance Shares of BCLI opened at $1.44 on Wednesday. The stock has a market capitalization of […]
